Funder: Ionis Pharmaceuticals
Due Dates: Rolling (applications must be submitted at least 60 days before program start date)
Funding Amounts: No fixed limits; award size and duration vary by project and available resources; funding is not guaranteed.
Summary: Supports independent, evidence-based medical education programs in hereditary angioedema (HAE) and severe hypertriglyceridemia (sHTG).
Key Information: Programs must be independent, unbiased, and free of industry influence; no support for ATTR topics.